Erschienen in:
23.11.2023 | ASO Author Reflections
ASO Author Reflections: Impact of Universal Germline Genetic Testing on Clinical Management in Rural Breast Cancer Patients
verfasst von:
Charles Shelton, MD, Sarah M. Nielsen, MS
Erschienen in:
Annals of Surgical Oncology
|
Ausgabe 2/2024
Einloggen, um Zugang zu erhalten
Excerpt
The benefits associated with guiding clinical management using germline genetic testing (GGT) contributed to the American Society of Breast Surgeons recommending universal testing for all breast cancer patients.
1 Still, there are few reports of the real-world clinical utility of universal GGT for breast cancer. Patients with breast cancer living in rural communities face a number of barriers to cancer care, with higher mortality rates compared with those living in metropolitan areas. Whether universal GGT could be implemented in a rural breast cancer practice has not been studied. …